Patient Derived Xenograft (PDX) Models Market Analysis and Size

The rise in support for cancer research is escalating the growth of patient derived xenograft (PDX) models market. Global Patient Derived Xenograft (PDX) Models Market was valued at USD 142,396.93 million in 2021 and is expected to reach USD 500,362.17 million by 2029, registering a CAGR of 17.01% during the forecast period of 2022-2029